Search results for "Statins"
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/07/latest-updates-on-acps-priorities-initiatives.htm
1 Jul 2024
Statins safe, offer benefits even in very old patients
Reductions in cardiovascular disease (CVD) after statin therapy were seen in patients up to ages 85 years or older without increasing risks for severe adverse effects.
https://immattersacp.org/weekly/archives/2024/05/28/1.htm
28 May 2024
Recommendations released on statin therapy for people with HIV
The guidance from a panel of the U.S. Department of Health and Human Services addresses primary prevention of atherosclerotic cardiovascular disease in patients ages 40 to 75 years and younger than age 40 years.
https://immattersacp.org/weekly/archives/2024/03/05/2.htm
5 Mar 2024
U.S. statin use plateaued in 2013 to 2018
Most U.S. adults with the strongest guideline recommendations for primary prevention with statins are not receiving them, including those with diabetes, extremely high cholesterol levels, or 10-year risk of cardiovascular disease over 20%, a study found.
https://immattersacp.org/weekly/archives/2023/12/05/1.htm
5 Dec 2023
Take a team approach to coronary disease
A major update to a cardiology guideline puts team-based, patient-centered care at the forefront of management and highlights the role of healthy diet and exercise habits in reducing cardiovascular risk.
https://immattersacp.org/archives/2024/02/take-a-team-approach-to-coronary-disease.htm
1 Feb 2024
Statins underused in patients with cardiovascular disease, study finds
Women, older adults, and those with peripheral artery disease and cerebrovascular disease are particularly likely not to receive statins, according to an industry-funded analysis of lipid-lowering therapy use.
https://immattersacp.org/weekly/archives/2023/08/08/2.htm
8 Aug 2023
The never-ending push-pull of statins
Statins have proven their potential to reduce end-point outcomes, such as death from cardiovascular disease. But the drug class also has some downsides, and the pros and the cons become a close call.
https://immattersacp.org/archives/2017/04/statins.htm
1 Apr 2017
Statins not associated with memory or cognition decline in elderly
Statins were associated with preserved cognitive ability in some subgroups, and the study may offer reassurance to patients concerned about statins' effects on the brain, study authors wrote.
https://immattersacp.org/weekly/archives/2019/11/19/4.htm
19 Nov 2019
Statin uptake suboptimal in PAD, industry-funded study finds
Patients with peripheral artery disease (PAD) were less likely to be taking statins than those with cerebrovascular disease or coronary heart disease, despite a high risk for atherosclerotic events.
https://immattersacp.org/weekly/archives/2020/07/14/4.htm
14 Jul 2020
EHR alert had small effect on lipid therapy in highest-risk patients
A trial alert nudged clinicians seeing patients with very high-risk atherosclerotic cardiovascular disease to intensify therapy by prescribing a high-intensity statin, adding ezetimibe, or prescribing a proprotein subtilisin/kexin type 9 inhibitor.
https://immattersacp.org/weekly/archives/2024/04/30/4.htm
30 Apr 2024